Clinical study of ursofalk and prostaglandin E1 on hepatic cirrhosis

CLINICAL FOCUS ›› 2006, Vol. 21 ›› Issue (12): 847-849.

Previous Articles Next Articles

Clinical study of ursofalk and prostaglandin E1 on hepatic cirrhosis

GUO Li-hong;LIU Li-ping;WANG Hai-fang;LI Bao-xing

Online:2006-06-20 Published:2006-06-20

Abstract

CLC Number:

R575.2

GUO Li-hong;LIU Li-ping;WANG Hai-fang;LI Bao-xing. Clinical study of ursofalk and prostaglandin E1 on hepatic cirrhosis[J]. CLINICAL FOCUS, 2006, 21(12): 847-849.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2006/V21/I12/847

[1]	Wang Qingli;Yang Lin;Liu Qi. Clinical observation on effect of coffeic acid on leukocyte anal platelet count in patients with cirrhosis [J]. Clinical Focus, 2015, 30(9): 1027-1.0281e+007.
[2]	Ge Xiuzhen;Wang Yuming;Zheng Zhongqing;Wang Tao;Wang Bangmao. Risk factors in poor prognosis after endoscopic variceal ligation and endoscopic injection sclerotherapy of esophageal varices caused by liver cirrhosis [J]. Clinical Focus, 2015, 30(3): 250-252256.
[3]	. [J]. CLINICAL FOCUS, 2014, 29(3): 350-350.
[4]	HE Qing-hong;HUANG Wei. Application of color Doppler sonography predicting cirrhotic portal hypertension with esophageal varices rupture hemorrhage [J]. CLINICAL FOCUS, 2014, 29(3): 295-297.
[5]	XIAO Qi;FENG Ai-dong;LIU Zhi-quan;FENG Jun-hua;DU Rui-qing;YE Li-hong;MEI Zhi-qin;DAI Er-hei. Value and impact factors of transient edoi:graphy in diagnosis of hepatitis B cirrhosis [J]. CLINICAL FOCUS, 2013, 28(8): 855-857860.
[6]	ZHAO Tian-yu;MA Chun-ye;LI Chun-yan. Analysis of cirrhosis patients with hepatic encephalopathy prognostic factors [J]. Clinical Focus, 2013, 28(4): 406-408.
[7]	WANG Jun-ming;CHEN Chun-yan;LI Yan;HANG Jing-xian;ZHANG Zhi-gang. Relationship between fatty liver and carotid atherosclerosis in different age populations [J]. Clinical Focus, 2013, 28(1): 11-13.
[8]	ZHANG Jing;SANG Hai-tong. Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome [J]. Clinical Focus, 2012, 27(24): 2117-2120.
[9]	. [J]. Clinical Focus, 2012, 27(22): 1979-1980.
[10]	LI Chun-sheng;GUO Jin-bo;XU Yun-feng;TIAN Hui;WEI Juan;ZHANG Guo-zun;LIU Lei;FANG Shu-ming;ZHANG Xiao-lan. Effects of salvia miltiorrhiza monomer IH764-3 on collagen metabolism and mechanism in hepatic stellate cells [J]. Clinical Focus, 2012, 27(17): 1502-1505.
[11]	. [J]. Clinical Focus, 2012, 27(6): 550-552.
[12]	. [J]. Clinical Focus, 2012, 27(3): 222-223.
[13]	. [J]. Clinical Focus, 2011, 26(24): 2158-2159.
[14]	. [J]. Clinical Focus, 2011, 26(22): 2005-2006.
[15]	. [J]. CLINICAL FOCUS, 2011, 26(19): 1718-1719.

Clinical study of ursofalk and prostaglandin E1 on hepatic cirrhosis

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments